finance.yahoo.com
VIVUS Reports Second Quarter 2019 Financial Results
CAMPBELL, Calif., Aug. 06, 2019 -- VIVUS, Inc. (NASDAQ: VVUS) (the “Company”), a specialty pharmaceutical company committed to the development and commercialization of.